(Q39909667)

15 September 2017

title

Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco (English)

1 reference

15 September 2017

0 references

0 references

1 reference

Evolutionary dynamics

1 reference

5

Sally Blower

1 reference

15 September 2017

Robert J Smith

1

1 reference

15 September 2017

Justin T Okano

series ordinal

2

1 reference

15 September 2017

James S Kahn

series ordinal

3

1 reference

15 September 2017

Erin N Bodine

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

14 January 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

327

1 reference

15 September 2017

issue

5966

1 reference

15 September 2017

page(s)

697-701

1 reference

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Will the drugs still work? Transmission of resistant HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?"

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Short communication: the number of HIV major NRTI mutations correlates directly with other antiretroviral-associated mutations and indirectly with replicative capacity and reduced drug susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Preventing and managing antiretroviral drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

The challenge of HIV-1 subtype diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1180556

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1180556

1 reference

15 September 2017

1 reference